Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Francesco, Agustoni"'
Autor:
Giulia Maria Stella, Vittorio Chino, Paola Putignano, Francesco Bertuccio, Francesco Agustoni, Laura Saracino, Stefano Tomaselli, Jessica Saddi, Davide Piloni, Chandra Bortolotto
Publikováno v:
Tomography, Vol 9, Iss 2, Pp 759-767 (2023)
Background and rationale. Novel coronavirus-related disease (COVID-19) has profoundly influenced hospital organization and structures worldwide. In Italy, the Lombardy Region, with almost 17% of the Italian population, rapidly became the most severel
Externí odkaz:
https://doaj.org/article/d8d0e4b989d648dbb98d84150982285e
Autor:
Riccardo Caccialanza, Emanuele Cereda, Francesco Agustoni, Catherine Klersy, Amanda Casirati, Elisabetta Montagna, Simona Carnio, Silvia Novello, Michele Milella, Sara Pilotto, Ilaria Trestini, Lucio Buffoni, Alessandra Ferrari, Paolo Pedrazzoli
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Nutritional support, including nutritional counseling and oral nutritional supplements (ONS), has been recommended as a first-line strategy in patients with non-small cell lung cancer (NSCLC). Evidence on the efficacy of immunonut
Externí odkaz:
https://doaj.org/article/9683b02c81fe40d698ce876eb13e4111
Autor:
Gennaro Ciliberto, Marco Canfora, Irene Terrenato, Chiara Agnoletto, Francesco Agustoni, Loredana Amoroso, Gustavo Baldassarre, Giuseppe Curigliano, Angelo Delmonte, Antonella De Luca, Michelangelo Fiorentino, Vanesa Gregorc, Toni Ibrahim, Chiara Lazzari, Angela Mastronuzzi, Paolo Pronzato, Armando Santoro, Giovanni Scambia, Stefania Tommasi, Andrea Vingiani, Patrizio Giacomini, Ruggero De Maria
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-5 (2022)
Abstract Background Molecular tumor boards (MTBs) match molecular alterations with targeted anticancer drugs upon failure of the available therapeutic options. Special and local needs are most likely to emerge through the comparative analysis of MTB
Externí odkaz:
https://doaj.org/article/84b8b9ca44364bdc9a492d814dd3d47c
Autor:
Francesco Falanga, Pietro Rinaldi, Cristiano Primiceri, Chandra Bortolotto, Olga Oneta, Francesco Agustoni, Patrizia Morbini, Laura Saracino, Dimitrios Eleftheriou, Federico Sottotetti, Giulia Maria Stella
Publikováno v:
Thoracic Cancer, Vol 13, Iss 19, Pp 2792-2798 (2022)
Abstract Surgery is part of a multimodal therapeutic approach to malignant pleural mesothelioma (MPM) although its real beneficial effect is still controversial. The optimal precise sequence of treatments within the trimodality is unclear, and should
Externí odkaz:
https://doaj.org/article/f98306515c484f168e820ef411d9e99c
Autor:
Raffaella Fiamma Cabini, Francesca Brero, Andrea Lancia, Chiara Stelitano, Olga Oneta, Elena Ballante, Emanuela Puppo, Manuel Mariani, Emanuele Alì, Valentina Bartolomeo, Marianna Montesano, Elisa Merizzoli, Diana Aluia, Francesco Agustoni, Giulia Maria Stella, Roger Sun, Linda Bianchini, Eric Deutsch, Silvia Figini, Chandra Bortolotto, Lorenzo Preda, Alessandro Lascialfari, Andrea Riccardo Filippi
Publikováno v:
Insights into Imaging, Vol 13, Iss 1, Pp 1-9 (2022)
Abstract Background and purpose In the retrospective-prospective multi-center "Blue Sky Radiomics” study (NCT04364776), we plan to test a pre-defined radiomic signature in a series of stage III unresectable NSCLC patients undergoing chemoradiothera
Externí odkaz:
https://doaj.org/article/e21802402d834519b32fbfa7a54f27b1
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study
Autor:
Laura Saracino, Chandra Bortolotto, Stefano Tomaselli, Elia Fraolini, Matteo Bosio, Giulia Accordino, Francesco Agustoni, David M. Abbott, Emma Pozzi, Dimitrios Eleftheriou, Patrizia Morbini, Pietro Rinaldi, Cristiano Primiceri, Andrea Lancia, Patrizia Comoli, Andrea R. Filippi, Giulia M. Stella
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy that most commonly affects the pleural layers. MPM has a strong association with asbestos, mainly caused by exposure to its biopersistent fibers in at least
Externí odkaz:
https://doaj.org/article/a4194bca8a3d4894a399dd1da9cf8447
Autor:
Alessio Bruni, Vieri Scotti, Paolo Borghetti, Stefano Vagge, Salvatore Cozzi, Elisa D’Angelo, Niccolò Giaj Levra, Alessandra Fozza, Maria Taraborrelli, Gaia Piperno, Valentina Vanoni, Matteo Sepulcri, Marco Trovò, Valerio Nardone, Elisabetta Lattanzi, Said Bou Selman, Federica Bertolini, Davide Franceschini, Francesco Agustoni, Barbara Alicja Jereczek-Fossa, Stefano Maria Magrini, Lorenzo Livi, Frank Lohr, Andrea Riccardo Filippi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/0768392c0cb64c4c83ee24c74494057f
Autor:
Alessio Bruni, Vieri Scotti, Paolo Borghetti, Stefano Vagge, Salvatore Cozzi, Elisa D’Angelo, Niccolò Giaj Levra, Alessandra Fozza, Maria Taraborrelli, Gaia Piperno, Valentina Vanoni, Matteo Sepulcri, Marco Trovò, Valerio Nardone, Elisabetta Lattanzi, Said Bou Selman, Federica Bertolini, Davide Franceschini, Francesco Agustoni, Barbara Alicja Jereczek-Fossa, Stefano Maria Magrini, Lorenzo Livi, Frank Lohr, Andrea Riccardo Filippi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionFor unresectable stage III non-small cell lung cancer (NSCLC), the standard therapy consists of chemoradiotherapy (CRT) followed by durvalumab maintenance for responding patients. The present study reports on the safety and outcome of dur
Externí odkaz:
https://doaj.org/article/c19bbcb997264bcc8021500369c7f78b
Autor:
Jennifer, G Whisenant, Javier, Baena, Alessio, Cortellini, Li-Ching, Huang, Giuseppe Lo Russo, Luca, Porcu, Selina, K Wong, Christine, M Bestvina, Matthew, D Hellmann, Elisa, Roca, Hira, Rizvi, Isabelle, Monnet, Amel, Boudjemaa, Jacobo, Rogado, Pasello, Giulia, Natasha, B Leighl, Oscar, Arrieta, Avinash, Aujayeb, Ullas, Batra, Ahmed, Y Azzam, Mojca, Unk, Mohammed, A Azab, Ardak, N Zhumagaliyeva, Carlos, Gomez-Martin, Juan, B Blaquier, Erica, Geraedts, Giannis, Mountzios, Gloria, Serrano-Montero, Niels, Reinmuth, Linda, Coate, Melina, Marmarelis, Carolyn, J Presley, Fred, R Hirsch, Pilar, Garrido, Hina, Khan, Alice, Baggi, Celine, Mascaux, Balazs, Halmos, Giovanni, L Ceresoli, Mary, J Fidler, Vieri, Scotti, Anne-Cécile, Métivier, Lionel, Falchero, Enriqueta, Felip, Carlo, Genova, Julien, Mazieres, Umit, Tapan, Julie, Brahmer, Emilio, Bria, Sonam, Puri, Sanjay, Popat, Karen, L Reckamp, Floriana, Morgillo, Ernest, Nadal, Francesca, Mazzoni, Francesco, Agustoni, Jair, Bar, Federica, Grosso, Virginie, Avrillon, Jyoti, D Patel, Fabio, Gomes, Ehab, Ibrahim, Annalisa, Trama, Anna, C Bettini, Fabrice, Barlesi, Anne-Marie, Dingemans, Heather, Wakelee, Solange, Peters, Leora, Horn, Marina Chiara Garassino, Valter, Torri, TERAVOLT study group
Publikováno v:
Journal of Thoracic Oncology, 17(5), 661-674. Elsevier Science
Journal of Thoracic Oncology, 17(5), 661-674. International Association for the Study of Lung Cancer
Journal of Thoracic Oncology, 17(5), 661-674. International Association for the Study of Lung Cancer
Introduction: Patients with thoracic malignancies are at increased risk for mortality from coronavirus disease 2019 (COVID-19), and a large number of intertwined prognostic variables have been identified so far. Methods: Capitalizing data from the Th
Autor:
Andrea Riccardo Filippi, Francesco Agustoni, Stefano Arcangeli, Diego Cortinovis, Alessandra Ferrari, Daniela Cicognini, Jessica Saddi, Catherine Klersy, Paolo Pedrazzoli, Umberto Malapelle, Francesco Grossi
Introduction/background: This single-arm, phase 2, multi-center, study aims to assess the safety and efficacy of a regimen of induction chemo-immunotherapy followed by de-intensified, hypo-fractionated thoracic radiotherapy (RT) given concurrently wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d47b304dcd1f12404ad44c334a9ccd3f
https://hdl.handle.net/11588/911146
https://hdl.handle.net/11588/911146